JUSTIN BAKER
Family Nurse Practitioner · SAN ANTONIO, TX
Individual Active NPI 1396428793
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 890 | 258,778 | $24,209,482 | $6,211,174 | $4,944,481 |
| 2023 | 107 | 18,476 | $1,993,703 | $565,832 | $450,673 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J3111 | Injection, romosozumab-aqqg, 1 mg | 35,490 | $11 | $9 |
| J0897 | Injection, denosumab, 1 mg | 28,500 | $25 | $20 |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 25,500 | $1 | $1 |
| J1756 | Injection, iron sucrose, 1 mg | 13,100 | $0 | $0 |
| J3380 | Injection, vedolizumab, intravenous, 1 mg | 9,900 | $22 | $17 |
| J1561 | Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | 8,723 | $47 | $37 |
| J2350 | Injection, ocrelizumab, 1 mg | 8,400 | $50 | $40 |
| J3032 | Injection, eptinezumab-jjmr, 1 mg | 5,600 | $18 | $14 |
| J2182 | Injection, mepolizumab, 1 mg | 5,100 | $30 | $24 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 3,987 | $0 | $0 |
| J2357 | Injection, omalizumab, 5 mg | 3,930 | $38 | $30 |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 2,400 | $31 | $25 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Family Nurse Practitioner | 363LF0000X | ✓ | 1129710 | TX |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- No
Other Family Nurse Practitioner providers in Texas
- NPI 1639850274
- NPI 1447869540
- NPI 1366896888
- NPI 1881553360
- NPI 1568383081
- NPI 1225852148
- NPI 1427638162
- NPI 1033677414
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.